Adlawon, Lolita M.
HRN: 03-42-49 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/03/2025
CEFTRIAXONE 1G (VIAL)
12/03/2025
12/10/2025
IV
2g
OD
CAP MR
Checking Final Appropriateness
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes